We serve Chemical Name:2-oxo-1H-quinoline-4-carbonitrile CAS:63158-99-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-oxo-1H-quinoline-4-carbonitrile
CAS.NO:63158-99-6
Synonyms:4-CYANO-2-HYDROXYQUINOLINE;2-Oxo-1,2-dihydro-4-chinolincarbonitril;2-oxo-1,2-dihydro-quinoline-4-carbonitrile
Molecular Formula:C10H6N2O
Molecular Weight:170.16700
HS Code:2933499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:337.6ºC at 760 mmHg
Density:1.36g/cm3
Index of Refraction:1.702
PSA:56.91000
Exact Mass:170.04800
LogP:1.81208
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-CYANO-2-HYDROXYQUINOLINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-oxo-1,2-dihydro-quinoline-4-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Oxo-1,2-dihydro-4-chinolincarbonitril Use and application,2-oxo-1,2-dihydro-quinoline-4-carbonitrile technical grade,usp/ep/jp grade.
Related News: The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 2-oxo-1H-quinoline-4-carbonitrile manufacturer The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 2-oxo-1H-quinoline-4-carbonitrile supplier The insulin-only and bihormonal configurations may be helpful in diabetes. 2-oxo-1H-quinoline-4-carbonitrile vendor Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. 2-oxo-1H-quinoline-4-carbonitrile factory The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.
